Comparison of Autologous Conditioned Plasma Injection, Extracorporeal Shockwave Therapy, and Conventional Treatment for Plantar Fasciitis: A Randomized Trial
Abstract
Objectives: To evaluate the efficacy of autologous conditioned plasma (ACP) compared with extracorporeal shockwave (ESWT) and conventional treatments for plantar fasciitis.Design: Randomized trial.Setting: Sports medicine center in a tertiary care hospital.Patients: Fifty‐four subjects (age range, 29‐71 years) with unilateral chronic plantar fasciitis with more than 4 months of symptoms.Methods: Subjects randomized to 3 groups: 19 to ACP and conventional treatment (ACP group), 19 to ESWT and conventional treatment (ESWT group), and 16 to conventional treatment alone. Conventional treatment included stretching exercises and orthotics if indicated.Main Outcome Measurements: Outcomes were pain‐Visual Analog Scale (VAS), American Orthopaedic Foot and Ankle Society (AOFAS) ankle‐hindfoot scale, and ultrasound plantar fascia thickness assessed at baseline before treatment and at 1 month, 3 months, and 6 months after treatment.Results: VAS, AOFAS ankle‐hindfoot scale, and plantar fascia thickness improved in all groups. Significant VAS pain score improvements in the ACP group compared with conventional treatment at month 1 (P = .037) and for the ESWT group compared with conventional treatment at months 1, 3, and 6 (P = .017, P = .022, and P = .042). The AOFAS ankle‐hindfoot scale score improved in the ACP group at months 3 and 6 (P = .004 and P = .013) and, for the ESWT group, at months 1 and 3 (P = .011 and P = .003) compared with conventional treatment. Significant improvements in plantar fascia thickness were seen in the ACP group at months 1 and 3 compared with conventional treatments (P = .015 and P = .014) and at months 3 and 6 compared with the ESWT group (P = .019 and P = .027). No adverse events reported.Conclusions: Treatment of plantar fasciitis with ACP or ESWT plus conventional treatments resulted in improved pain and functional outcomes compared with conventional treatment alone. There was no significant difference between ACP and ESWT in terms of VAS and AOFAS ankle‐hindfoot scale improvements, although the ACP group demonstrated greater reductions in plantar fascia thickness.Keywords
Funding Information
- Singapore National Medical Research Committee
This publication has 36 references indexed in Scilit:
- Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich PlasmaThe American Journal of Sports Medicine, 2011
- Minimal Important Difference (MID) of two commonly used outcome measures for foot problemsJournal of Foot and Ankle Research, 2010
- Use of Autologous Platelet-rich Plasma to Treat Muscle Strain InjuriesThe American Journal of Sports Medicine, 2009
- Diagnostic imaging for chronic plantar heel pain: a systematic review and meta‐analysisJournal of Foot and Ankle Research, 2009
- Obesity and pronated foot type may increase the risk of chronic plantar heel pain: a matched case-control studyBMC Musculoskeletal Disorders, 2007
- The Roles of Growth Factors in Tendon and Ligament HealingSports Medicine, 2003
- Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: A rat patellar tendon modelActa Orthopaedica, 2000
- 12-Year Outcome After Modified Watson-Jones Tenodesis for Ankle InstabilityClinical Orthopaedics and Related Research, 1999
- Painful Heel Syndrome: Results of Nonoperative TreatmentFoot & Ankle International, 1994
- Clinical Rating Systems for the Ankle-Hindfoot, Midfoot, Hallux, and Lesser ToesFoot & Ankle International, 1994